Review: Drug-eluting stents for coronary artery disease do not reduce mortality more than bare-metal stents

Nordmann, A. J.; Briel, M.; Bucher, H. C.
May 2007
ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p66
Academic Journal
The article examines a study which compares the effectiveness of drug-eluting (DES) stents versus bare metal stents (BMS) in treating patients with coronary artery disease. Results revealed that DES and BMS did not differ in terms of total mortality or cardiac mortality at any follow-up interval. It is concluded that in patients with coronary artery disease, DES are not more effective in reducing mortality than BMS after implantation.


Related Articles

  • Review: Drug-eluting stents for coronary artery disease do not reduce mortality more than bare-metal stents: COMMENTARY. Bates, Eric R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p66 

    The author comments on a study which compares the effectiveness of drug-eluting (DES) stents versus bare metal stents (BMS) in patients with coronary artery disease. He asserted that the meta-analysis by researchers used to support DES labeling has indicated no long-term increase in death of...

  • Drug-eluting stents increased risk for late cardiac death or myocardial infarction more than bare-metal stents. Pfisterer, M.; Brunner-La Rocca, H. P.; Buser, P. T. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p67 

    The article presents a study which examines the effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with coronary artery disease who discontinue anti-platelet therapy. Results revealed that DES lessen the risk of having major cardiac events. It is concluded that...

  • TCT 2008 notebook.  // Medical Device Daily;10/14/2008, Vol. 12 Issue 218, p2 

    The article reports on data presented by Abbott from 30 patients in its clinical trial, demonstrating that its bioabsorbable drug-eluting stent (DES) successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years. It was noted that patients who...

  • The Latest Development in Heart Hardware. Voiland, Adam // U.S. News & World Report;7/21/2008, Vol. 145 Issue 2, p114 

    The article discusses the Xience V and Promus stents, drug-coated implants that hold open clogged arteries and are available for people with coronary disease. The article compares and contrasts these stents with previous stents used for coronary patients. Comments from cardiologist Jeffrey Moses...

  • COURAGE or FAME...? Who should have percutaneous coronary intervention in stable coronary artery disease? Fox, Keith A. A. // Heart;Apr2013, Vol. 99 Issue 7, p442 

    The article focuses on different perceptions in patients related to the treatment of stable coronary artery disease (CAD) using stent therapy. It informs that there was no difference in death rates and other cardiovascular events between patients undergoing revascularisation and those undergoing...

  • A message from Dr. Kereiakes. Kereiakes, Dean J. // Cincinnati Magazine;Dec2012, Vol. 46 Issue 3, special section p2 

    An introduction to the special issue of the journal is presented in which the editor discusses the cutting-edge approach to the treatment of coronary artery disease with bioresorbable vascular scaffold coronary stents.

  • Statins Modulate Outcomes in Acute Coronary Syndromes. Sadovsky, Richard // American Family Physician;4/1/2005, Vol. 71 Issue 7, p1416 

    Discusses research being done on the use of statins in treating acute coronary syndromes. Reference to a study by F. A. Spencer et al, published in the June 1, 2004 issue of the journal "Annals of Internal Medicine"; Procedures for the study; Efficacy of the treatment method.

  • Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies. Wever, Kimberley E.; Hooijmans, Carlijn R.; Riksen, Niels P.; Sterenborg, Thomas B.; Sena, Emily S.; Ritskes-Hoitinga, Merel; Warlé, Michiel C. // PLoS ONE;11/18/2015, Vol. 10 Issue 11, p1 

    Background: Ischemic preconditioning (IPC) of the heart is a protective strategy in which a brief ischemic stimulus immediately before a lethal ischemic episode potently limits infarct size. Although very promising in animal models of myocardial infarction, IPC has not yet been successfully...

  • Cholesterol Management: The Complexity of Multiple Effectives Treatments. McCarter, Thomas // American Health & Drug Benefits;Nov/Dec2008, Vol. 1 Issue 9, p48 

    The article considers the effectiveness of different treatments for managing the level of cholesterol. Bringing down the level of cholesterol has been proven to effectively reduce mortality and morbidity linked to acute coronary syndromes and stroke. The availability of numerous effective...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics